Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Higher dose of methimazole causes frequent adverse effects in the management of Graves' disease in children and adolescents.

Sato H, Sasaki N, Minamitani K, Minagawa M, Kazukawa I, Sugihara S, Wataki K, Konda S, Inomata H, Sanayama K, Kohno Y.

J Pediatr Endocrinol Metab. 2012;25(9-10):863-7. doi: 10.1515/jpem-2012-0138.

PMID:
23426814
2.

Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.

Sato H, Minagawa M, Sasaki N, Sugihara S, Kazukawa I, Minamitani K, Wataki K, Konda S, Inomata H, Sanayama K, Kohno Y.

J Pediatr Endocrinol Metab. 2011;24(5-6):257-63.

PMID:
21823520
3.

Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves' disease compared with adolescent patients.

Sato H, Minamitani K, Minagawa M, Kazukawa I, Sugihara S, Wataki K, Konda S, Inomata H, Sanayama K, Kohno Y, Sasaki N.

J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):677-83. doi: 10.1515/jpem-2013-0288.

PMID:
24756042
4.

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.

Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N.

J Clin Endocrinol Metab. 2007 Jun;92(6):2157-62. Epub 2007 Mar 27.

PMID:
17389704
5.

Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.

Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K, Nagataki S, Taniyama M.

Thyroid. 2015 Jan;25(1):43-50. doi: 10.1089/thy.2014.0084.

PMID:
25178068
6.

The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.

Tsuboi K, Ueshiba H, Shimojo M, Ishikawa M, Watanabe N, Nagasawa K, Yuasa R, Yoshino G.

Endocr J. 2007 Feb;54(1):39-43. Epub 2006 Oct 20.

7.

Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.

Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A.

Clin Endocrinol (Oxf). 2010 Jun;72(6):845-50. doi: 10.1111/j.1365-2265.2009.03745.x. Epub 2009 Nov 11.

PMID:
19912243
8.

Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.

Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A.

Clin Endocrinol (Oxf). 2001 Mar;54(3):385-90.

PMID:
11298092
9.

Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.

He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.

Clin Endocrinol (Oxf). 2004 Jun;60(6):676-81.

PMID:
15163329
10.

Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.

Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A.

Thyroid. 2009 Jun;19(6):559-63. doi: 10.1089/thy.2008.0364.

PMID:
19445623
11.

Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.

Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.

Clin Invest Med. 1999 Aug;22(4):132-9.

PMID:
10497711
12.

Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.

Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K.

Thyroid. 2015 Oct;25(10):1155-61. doi: 10.1089/thy.2014.0581. Epub 2015 Aug 28.

PMID:
26222916
13.

A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.

Reinwein D, Benker G, Lazarus JH, Alexander WD.

J Clin Endocrinol Metab. 1993 Jun;76(6):1516-21.

PMID:
8501160
14.

Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.

Kallner G, Vitols S, Ljunggren JG.

J Intern Med. 1996 Jun;239(6):525-9.

PMID:
8656146
15.
16.

Treatment of hyperthyroidism with a small single daily dose of methimazole: a prospective long-term follow-up study.

Mashio Y, Beniko M, Matsuda A, Koizumi S, Matsuya K, Mizumoto H, Ikota A, Kunita H.

Endocr J. 1997 Aug;44(4):553-8.

17.

Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.

Toderian AB, Lawson ML.

Pediatrics. 2014 May;133(5):e1401-4. doi: 10.1542/peds.2013-1857.

18.

[Evaluation of the medical treatment of Graves' disease (GD)].

Peixoto MC, Coeli CM, Vaisman M.

Arq Bras Endocrinol Metabol. 2005 Jun;49(3):410-9. Epub 2006 Mar 16. Portuguese.

19.

Acute pancreatitis induced by methimazole in a patient with Graves' disease.

Yang M, Qu H, Deng HC.

Thyroid. 2012 Jan;22(1):94-6. doi: 10.1089/thy.2011.0210. Epub 2011 Dec 2.

PMID:
22136208
20.

Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.

Kawakami-Tani T, Fukawa E, Tanaka H, Abe Y, Makino I.

Metabolism. 1997 Oct;46(10):1184-8.

PMID:
9322804

Supplemental Content

Support Center